Compare ANDE & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANDE | HROW |
|---|---|---|
| Founded | 1947 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.7B |
| IPO Year | 2005 | N/A |
| Metric | ANDE | HROW |
|---|---|---|
| Price | $70.73 | $34.10 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $75.00 | $71.14 |
| AVG Volume (30 Days) | 276.3K | ★ 924.6K |
| Earning Date | 05-20-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.12% | N/A |
| EPS Growth | ★ 12.93 | N/A |
| EPS | ★ 0.82 | N/A |
| Revenue | ★ $11,008,928,000.00 | N/A |
| Revenue This Year | $7.26 | $44.68 |
| Revenue Next Year | $3.59 | $40.71 |
| P/E Ratio | $86.94 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $31.03 | $20.85 |
| 52 Week High | $71.54 | $54.98 |
| Indicator | ANDE | HROW |
|---|---|---|
| Relative Strength Index (RSI) | 62.83 | 27.80 |
| Support Level | $62.29 | $30.55 |
| Resistance Level | N/A | $40.64 |
| Average True Range (ATR) | 2.20 | 2.54 |
| MACD | 0.29 | -1.45 |
| Stochastic Oscillator | 86.88 | 2.31 |
Andersons Inc is an agriculture and renewable fuels company. Its operations are classified into two reportable business segments: Agribusiness, which generates maximum revenue, and Renewables. The Agribusiness segment includes merchandising and managing logistics across various commodities, as well as being a manufacturer, distributor, and retailer of agricultural and related plant nutrients. The segment specializes in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. The Renewables segment mainly produces, purchases, and sells ethanol and co-products. Geographically, the company generates maximum revenue from the United States, followed by Canada, Mexico, and other markets.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.